QCM
ANIK icon

Quantinno Capital Management’s Anika Therapeutics ANIK Stock Holding History

Quantinno Capital Management’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.27M Buy
155,257
+29,431
+23% +$436K ﹤0.01% 1870
2026
Q1 		$1.82M Buy
125,826
+24,277
+24% +$282K ﹤0.01% 1684
2025
Q4 		$976K Buy
101,549
+42,955
+73% +$411K ﹤0.01% 1814
2025
Q3 		$551K Buy
58,594
+45,186
+337% +$432K ﹤0.01% 1930
2025
Q2 		$142K Buy
+13,408
New +$169K ﹤0.01% 2451

Other funds holding ANIK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $666M AUM 17.17% 1-Year Est. Return

Quantinno Capital Management's ANIK Position: Q2 2026 in Review

Quantinno Capital Management increased its Anika Therapeutics (ANIK) stake by 23% in Q2 2026, buying an estimated $436K and bringing the position to 155,257 shares worth $2.27M. The position accounts for ﹤0.01% of the portfolio, ranked #1870.

Quantinno Capital Management first reported a position in ANIK in Q2 2025 and has held it in 5 quarters since. 133 funds tracked by Wall St. Rank hold ANIK as of Q2 2026.

  • Quantinno Capital Management held 155,257 shares of Anika Therapeutics worth $2.27M as of Q2 2026.
  • Quantinno Capital Management bought 29,431 Anika Therapeutics shares in Q2 2026, an estimated $436K.
  • Anika Therapeutics made up ﹤0.01% of Quantinno Capital Management's portfolio in Q2 2026, its #1870 holding.
  • Quantinno Capital Management first reported a position in Anika Therapeutics in Q2 2025 and has held it in 5 quarters since.
  • 133 funds tracked by Wall St. Rank held Anika Therapeutics as of Q2 2026.

Based on Quantinno Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.